Myriad Genetics Inc. Registered Shares DL -,01

Sector and Industry

Healthcare, Healthcare Equipment

Performance (1Y)

38.14%

Market Cap

1.74 Bil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-3.50 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Abbott Laboratories185.26 Bil.39.29 Bil.33.69
-53.32 %
0.00
-
Intuitive Surgical Inc171.24 Bil.8.92 Bil.71.93
+17.90 %
0.00
-
Boston Scientific Corp120.40 Bil.17.79 Bil.49.17
+49.88 %
0.00
-
Stryker Corp.114.47 Bil.22.26 Bil.41.85
+3.99 %
0.00
-
Medtronic PLC90.93 Bil.31.27 Bil.22.35
-4.61 %
0.00
-
Siemens Healthineers AG51.40 Bil.23.38 Bil.24.04
+10.40 %
0.00
-
Hoya Corp48.59 Bil.5.43 Bil.35.69
+17.33 %
0.00
-
Becton Dickinson and Co.45.46 Bil.19.79 Bil.32.18
-3.33 %
0.00
-
Edwards Lifesciences Corp42.15 Bil.5.38 Bil.47.11
-27.44 %
0.00
-
Alcon AG33.20 Bil.9.24 Bil.38.41
-7.56 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE4.963 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 04:32:17 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW5.1324.951
PREV. DAY'S PRICE5.194 (07/21)
CHANGE DAY BEFORE
-0.23
-4.45 %
52 WEEK HIGH / LOW7.1 (10/06)3.001 (05/18)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-2.94-1.30-3.500.060.11
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
--102.50(e)84.4345.46
PRICE - BOOK RATIO
2.201.791.56--
PRICE - SALES RATIO
2.101.480.69--
PRICE - CASH FLOW RATIO
--316.38--
Further Key Figures

Master Data

WKN
897518
ISIN
US62855J1043
SYMBOL
MYD
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Myriad Genetics
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Equipment
NUMBER OF SHARES
89.87 Mil.
MARKET CAPITALISATION
1.74 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-1.33 %
33.56 %
23.08 %
4.30 %
38.14 %
-75.03 %
-80.42 %
-2.00 %
HIGH5.555.555.555.557.1026.2031.035.95
LOW5.063.843.003.003.003.003.003.00

Dividende

pro Aktie
Myriad Genetics does not deliver dividend information

Company profile

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.